Last update 21 Nov 2024

Enavogliflozin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DWP16001 drug A, DWP16001 drug B
+ [4]
Target
Mechanism
SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
KR (06 Dec 2022),
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H27ClO6
InChIKeyKORCWPOBTZTAFI-YVTYUBGGSA-N
CAS Registry1415472-28-4

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
KR
06 Dec 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 3
KR
23 Sep 2024
Type 2 diabetes mellitus with established diabetic nephropathyPhase 3
KR
23 Sep 2024
Heart failure with normal ejection fractionPhase 3
KR
25 Oct 2023
Tricuspid Valve InsufficiencyPhase 3
KR
25 Oct 2023
Diabetes Mellitus, Type 2Phase 3
CN
31 Aug 2022
Diabetes MellitusPreclinical
KR
15 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
(hehqquqslh) = svfemddybw ftclmiclma (pzzgvyccwo )
Positive
19 Jun 2024
(hehqquqslh) = ollxknrdhg ftclmiclma (pzzgvyccwo )
Phase 3
160
(biwgiuxzpm): P-Value = <0.001
Positive
25 Jan 2022
Placebo
Phase 1
Glycosuria
glucosuria
-
(xbqiywfydc) = DWP16001 was well tolerated in all dose groups, and all adverse events were mild in severity shkwuwbwvm (niieokkyyn )
Positive
19 Sep 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free